Literature DB >> 11727403

Diabetes mellitus and coronary heart disease.

P W Wilson1.   

Abstract

Diabetes mellitus, especially type 2 diabetes, is a growing concern in America. Longitudinal trends show that obesity is more prevalent than in the past, and the incidence of type 2 diabetes is also increasing. Type 2 diabetes typically doubles the CHD risk in men and triples the risk in women. Intervening to control lipid levels and blood pressure has been shown to be especially helpful in preventing CHD, but the impact of better glycemic control on CHD risk is less convincing, especially in clinical trials. Revascularization studies in diabetics show that coronary bypass surgery is related to better outcomes than angioplasty procedures.

Entities:  

Mesh:

Year:  2001        PMID: 11727403     DOI: 10.1016/s0889-8529(05)70219-x

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  13 in total

Review 1.  [Heart failure in diabetes].

Authors:  Michael Resl; Martin Hülsmann; Richard Pacher; Martin Clodi
Journal:  Wien Med Wochenschr       Date:  2009

2.  Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation.

Authors:  Kooresh I Shoghi; Robert J Gropler; Terry Sharp; Pilar Herrero; Nicole Fettig; Yi Su; Mayurranjan S Mitra; Attila Kovacs; Brian N Finck; Michael J Welch
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

3.  In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy.

Authors:  Kooresh I Shoghi; Brian N Finck; Kenneth B Schechtman; Terry Sharp; Pilar Herrero; Robert J Gropler; Michael J Welch
Journal:  Circ Cardiovasc Imaging       Date:  2009-07-21       Impact factor: 7.792

4.  In vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats.

Authors:  Samuel Nemanich; Sudheer Rani; Kooresh Shoghi
Journal:  Obesity (Silver Spring)       Date:  2013-05-31       Impact factor: 5.002

5.  How does pioglitazone prevent progression of impaired glucose tolerance to diabetes?

Authors:  Saul M Genuth
Journal:  Diabetes       Date:  2013-11       Impact factor: 9.461

6.  Genomic and metabolic disposition of non-obese type 2 diabetic rats to increased myocardial fatty acid metabolism.

Authors:  Sriram Devanathan; Samuel T Nemanich; Attila Kovacs; Nicole Fettig; Robert J Gropler; Kooresh I Shoghi
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

7.  Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells.

Authors:  Christopher Lipina; Clare Stretton; Simon Hastings; Jonathan S Hundal; Ken Mackie; Andrew J Irving; Harinder S Hundal
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

8.  Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.

Authors:  Thomas Pulinilkunnil; Petra C Kienesberger; Jeevan Nagendran; Terri J Waller; Martin E Young; Erin E Kershaw; Gregory Korbutt; Guenter Haemmerle; Rudolf Zechner; Jason R B Dyck
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

9.  Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism.

Authors:  Sriram Devanathan; Timothy D Whitehead; Nicole Fettig; Robert J Gropler; Samuel Nemanich; Kooresh I Shoghi
Journal:  Biol Sex Differ       Date:  2016-05-13       Impact factor: 5.027

10.  Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Vasilios Papademetriou; Linda B Piller; Charles E Ford; David Gordon; Thomas J Hartney; Therese S Geraci; Efrain Reisin; Brian Montgomery Sumner; Nathan D Wong; Chuke Nwachuku; Puneet Narayan; Julian Haywood; Gabriel Habib
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.